Corpus ID: 34152904

Rapid Treatment of Subungual Onychomycosis Using Controlled Micro Nail Penetration and Terbinafine Solution.

@article{Bristow2016RapidTO,
  title={Rapid Treatment of Subungual Onychomycosis Using Controlled Micro Nail Penetration and Terbinafine Solution.},
  author={Ivan R. Bristow and Robert L. Baran and Michelle Score},
  journal={Journal of drugs in dermatology : JDD},
  year={2016},
  volume={15 8},
  pages={
          974-8
        }
}
Onychomycosis continues to be a common and intractable problem in adults, often responding poorly to topical treatment due to limited drug penetration of the nail plate. [...] Key Method The authors present three cases of toenail onychomycosis treated topical terbinafine 1% solution using controlled micro-penetration of the nail using a novel intelligent nail drill system which is able to drill nail plate without penetrating the delicate nail bed beneath. The cases illustrate how the device has been…Expand
6 Citations
Onychomycosis: Treatment and prevention of recurrence.
TLDR
The prognosis and response to onychomycosis treatment, medications that have been approved by the US Food and Drug Administration, and off-label therapies and devices are reviewed. Expand
Transungual Delivery of Ciclopirox Is Increased 3–4-Fold by Mechanical Fenestration of Human Nail Plate in an In Vitro Model
TLDR
In this work, an in vitro model of the transungual delivery of antifungal agents is presented, which utilizes real nail tissue and an inline flow system and determined that nail fenestration improved drug delivery by 3–4-fold after 42 days. Expand
Transungual Delivery of Ciclopirox Is Increased 3–4-Fold by Mechanical Fenestration of Human Nail Plate in an In Vitro Model
TLDR
In this work, an in vitro model of the transungual delivery of antifungal agents is presented, which utilizes real nail tissue and an inline flow system and determined that nail fenestration improved drug delivery by 3–4-fold after 42 days. Expand
Onychomycosis: An Updated Review
  • A. K. Leung, J. M. Lam, +4 authors Alex H.C. Wong
  • Medicine
  • Recent patents on inflammation & allergy drug discovery
  • 2019
TLDR
There is a need for exploring more effective and/or alternative treatment modalities for the treatment of onychomycosis which are safer and more effective. Expand
MacGyver Jobs in Dermatology
Background: Hair loss is a common clinical presentation in any medical clinic. Telogen effluvium is considered among the most prevalent causes of hair loss particularly in female patients. TelogenExpand
Onychomycosis

References

SHOWING 1-10 OF 21 REFERENCES
The effectiveness of lasers in the treatment of onychomycosis: a systematic review
  • I. Bristow
  • Medicine
  • Journal of Foot and Ankle Research
  • 2014
TLDR
The evidence pertaining to the effectiveness of laser treatment of onychomycosis is limited and of poor methodological quality, and future studies using a randomised controlled trial designs with larger study populations and clear procedures are required to permit a full evaluation of this emerging technology. Expand
How Low Should You Go: Novel Device for Nail Trephination
TLDR
Mesoscission or microcutting technology to create holes of specific depths in the nail plate without penetrating the nail bed may be a controlled and practical alternative to traditional nail trephining methods. Expand
Efficacy of debridement alone versus debridement combined with topical antifungal nail lacquer for the treatment of pedal onychomycosis: a randomized, controlled trial.
TLDR
Patients in the antifungal nail lacquer group improved statistically significantly more than did those in the debridement alone group, and displayed a 76.74% rate of mycological cure. Expand
The use of the Er:YAG 2940nm laser associated with amorolfine lacquer in the treatment of onychomycosis*
TLDR
It is believed that ablative lasers can increase the efficacy of topical onychomycosis treatment, and partial results have shown an increase in areas of nail plate free of disease. Expand
The Presence of an Air Gap Between the Nail Plate and Nail Bed in Onychomycosis Patients: Treatment Implications for Topical Therapy.
TLDR
This study suggests that the low surface tension vehicle developed for efinaconazole topical solution, 10% can reach the site of infection by application to the hyponychium, dorsal or ventral nail surface and nail folds. Expand
Onychomycosis. Treatment, quality of life, and economic issues.
  • B. Elewski
  • Medicine
  • American journal of clinical dermatology
  • 2000
TLDR
Onychomycosis can be treated effectively and with comparative safety with the new generation of oral antifungal agents (itraconazole, fluconazole and terbinafine) and significantly improved pharmacokinetic and pharmacodynamic profiles permit markedly reduced duration of administration, individual drug exposure, and ultimately enhanced patient compliance and satisfaction with therapy. Expand
Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey
TLDR
Toenail onychomycosis was present in 26% of the sample and is projected to affect approximately one‐third of subjects with diabetes, and Predisposing factors include increasing age, male gender, family history of onyChomyCosis, concurrent intake of immunosuppressive agents and peripheral vascular disease. Expand
Topical and oral combination therapy for toenail onychomycosis: an updated review.
TLDR
Although effective, oral antifungal therapy is still not completely successful, and additional measures, such as mechanical intervention, may help improve response rates further. Expand
The effect of toenail onychomycosis on patient quality of life
  • B. Elewski
  • Medicine
  • International journal of dermatology
  • 1997
TLDR
A previous study has suggested that this is not the case and that toenail and fingernail onychomycosis adversely impacts patient quality of life (QOL). Expand
Cumulative meta‐analysis of systemic antifungal agents for the treatment of onychomycosis
TLDR
The most common oral therapies for dermatophyte toenail onychomycosis include terbinafine, itraconazole and fluconazole. Expand
...
1
2
3
...